Lijun Xu

710 total citations
36 papers, 505 citations indexed

About

Lijun Xu is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Lijun Xu has authored 36 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 13 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Lijun Xu's work include Immune Cell Function and Interaction (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immunotherapy and Immune Responses (6 papers). Lijun Xu is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immunotherapy and Immune Responses (6 papers). Lijun Xu collaborates with scholars based in China and United States. Lijun Xu's co-authors include Dongrong Yang, Bingyu Li, Xiaohong Chen, Yuhchyau Chen, Peter C. Keng, Soo Ok Lee, Ying Tsai, Mingjing Shen, Jin Zhu and Lihong He and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Lijun Xu

33 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lijun Xu China 13 212 196 156 96 86 36 505
Takaaki Oba Japan 16 304 1.4× 425 2.2× 177 1.1× 85 0.9× 73 0.8× 45 716
David Soler United States 12 249 1.2× 94 0.5× 134 0.9× 60 0.6× 38 0.4× 26 505
Sonia Patel United States 8 106 0.5× 204 1.0× 187 1.2× 105 1.1× 84 1.0× 13 506
Jun Osugi Japan 11 131 0.6× 209 1.1× 164 1.1× 104 1.1× 110 1.3× 31 412
E. Sato Japan 12 183 0.9× 169 0.9× 101 0.6× 132 1.4× 75 0.9× 17 508
Hui Tang China 12 104 0.5× 242 1.2× 204 1.3× 114 1.2× 111 1.3× 33 563
Chenyu Mao China 15 133 0.6× 298 1.5× 224 1.4× 160 1.7× 74 0.9× 61 661
Jolanta Libura United States 9 160 0.8× 242 1.2× 200 1.3× 76 0.8× 70 0.8× 13 585
Jiunn-Chang Lin Taiwan 11 124 0.6× 152 0.8× 150 1.0× 84 0.9× 79 0.9× 27 426

Countries citing papers authored by Lijun Xu

Since Specialization
Citations

This map shows the geographic impact of Lijun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijun Xu more than expected).

Fields of papers citing papers by Lijun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijun Xu. The network helps show where Lijun Xu may publish in the future.

Co-authorship network of co-authors of Lijun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lijun Xu. A scholar is included among the top collaborators of Lijun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijun Xu. Lijun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Lijun, et al.. (2025). Dual targeting of ENPP3 and SIRPα with a bispecific antibody enhances macrophage-mediated immunity in renal cell carcinoma. Biochemical and Biophysical Research Communications. 769. 151955–151955.
2.
Xu, Lijun, et al.. (2025). Targeting ALPPL2 with a novel CD89 bispecific antibody reprograms macrophages to enhance anti-tumor immunity. Biochemical and Biophysical Research Communications. 762. 151761–151761. 3 indexed citations
3.
Li, Li, Yuanji Xu, Ke Xu, et al.. (2024). EP.12D.06 Real-World Cases on Efficacy and Safety of Savolitinib for Elderly Patients with NSCLC Harbouring METex14 Skipping Mutations. Journal of Thoracic Oncology. 19(10). S652–S652.
4.
5.
Xu, Lijun, Bingyu Li, Zhaohua Zhu, et al.. (2022). Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade. Journal for ImmunoTherapy of Cancer. 10(12). e005447–e005447. 11 indexed citations
6.
Wang, Fei, Tong Chen, Hanbing Chen, et al.. (2021). Clinically significant prostate cancer (csPCa) detection with various prostate sampling schemes based on different csPCa definitions. BMC Urology. 21(1). 183–183. 9 indexed citations
7.
Xu, Lijun & Qing Zheng. (2021). CHD3/4/5/6/8 serve as potential prognostic predictors in human gastric cancer. Network Modeling Analysis in Health Informatics and Bioinformatics. 10(1). 1 indexed citations
8.
Xu, Ming, Lijun Xu, Yin Wang, et al.. (2020). BRD4 inhibition sensitizes renal cell carcinoma cells to the PI3K/mTOR dual inhibitor VS-5584. Aging. 12(19). 19147–19158. 9 indexed citations
9.
Chen, Xiaohong, Feng Chen, Yu Ren, et al.. (2019). IL-6 signaling contributes to radioresistance of prostate cancer through key DNA repair-associated molecules ATM, ATR, and BRCA 1/2. Journal of Cancer Research and Clinical Oncology. 145(6). 1471–1484. 19 indexed citations
10.
Xu, Lijun, et al.. (2019). CD47/SIRPα blocking enhances CD19/CD3-bispecific T cell engager antibody-mediated lysis of B cell malignancies. Biochemical and Biophysical Research Communications. 509(3). 739–745. 17 indexed citations
11.
12.
Xu, Lijun, Mingjing Shen, Xiaohong Chen, et al.. (2018). In vitro -induced M2 type macrophages induces the resistance of prostate cancer cells to cytotoxic action of NK cells. Experimental Cell Research. 364(1). 113–123. 10 indexed citations
13.
Zhang, Lan, Lijun Xu, Jin Zhu, et al.. (2018). ATM‑JAK‑PD‑L1 signaling pathway inhibition decreases EMT and metastasis of androgen‑independent prostate cancer. Molecular Medicine Reports. 17(5). 7045–7054. 19 indexed citations
14.
15.
Li, Bingyu, Lijun Xu, Kun Xie, et al.. (2017). Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activityin vivo. Oncotarget. 8(24). 39356–39366. 19 indexed citations
16.
Xu, Lijun, Bingyu Li, Mengwen Huang, et al.. (2016). Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy. PLoS ONE. 11(7). e0159426–e0159426. 14 indexed citations
17.
Gong, Liang, et al.. (2016). Clinical effect of treating secondary asthma attacks of children Mycoplasma pneumoniae with combined therapy of montelukast and azithromycin.. PubMed. 20(24). 5256–5260. 5 indexed citations
18.
Xu, Lijun, et al.. (2014). In vivo determination of muscle-derived stem cells in the rat corpus cavernosum. Experimental and Therapeutic Medicine. 8(1). 274–280. 2 indexed citations
19.
Xu, Lijun, et al.. (2012). Hypoxic hepatitis: a challenging diagnosis. Hepatology International. 6(4). 663–669. 17 indexed citations
20.
Yang, Li, et al.. (2009). [Effects of bone morphogenic proteins-7 on production of collagen from hepatocytes and hepatic stellate cells during liver fibrosis].. PubMed. 89(6). 419–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takaaki Oba Breakdown of academic impact, for papers by David Soler Breakdown of academic impact, for papers by Sonia Patel Breakdown of academic impact, for papers by Jun Osugi Breakdown of academic impact, for papers by E. Sato Breakdown of academic impact, for papers by Hui Tang Breakdown of academic impact, for papers by Chenyu Mao Breakdown of academic impact, for papers by Jolanta Libura Breakdown of academic impact, for papers by Jiunn-Chang Lin
Rankless by CCL
2026